Subtitle: National APAMSA Hepatitis B and Conference – November 2014
BOSTON, MA — On Saturday, November 8, 2014, the Asian Pacific American Medical Student Association (APAMSA)
hosted its annual National APAMSA Hepatitis B and C Conference
featuring some of the world’s leading hepatologists. Through a series of
lectures and a research poster session, the annual conference seeks to
inform medical and premedical students about the current developments in
Hepatitis B&C treatment and prevention. A physician-student
mentorship luncheon session also presents additional opportunities for
conference attendees to engage in discussions about Hepatitis B and C
outreach efforts in their local communities.
With over 2 billion people in world affected by HBV in
the past and present, and with 15-40% those cases developing liver
cirrhosis, liver disease, or liver cancer, we really have the
opportunity to have a global impact in treating this disease.
– Dr. Daryl Lau
Although Hepatitis B (HBV) and Hepatitis C (HCV) are not identical
viruses, they are transmitted through similar methods and both are among
the leading causes of liver cancer in the world. HBV and HCV are
commonly referred to as the “silent killers”
because infected patients can remain asymptomatic for many years and
may not experience symptoms until the infection has progressed to
chronic stages, resulting in severe liver disease or cancer. Therefore,
those infected
Read more...
Labels: Asian Americans and Pacific Islanders (AAPIs), Asian Pacific American Medical Student Association (APAMSA)